587 related articles for article (PubMed ID: 12446975)
21. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory treatment in AD mice protects against neuronal pathology.
Choi JK; Jenkins BG; Carreras I; Kaymakcalan S; Cormier K; Kowall NW; Dedeoglu A
Exp Neurol; 2010 Jun; 223(2):377-84. PubMed ID: 19679126
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.
Cole GM; Frautschy SA
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):140-8. PubMed ID: 20205646
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase as a target for the antiamyloidogenic activities of nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
Pasinetti GM
Neurosignals; 2002; 11(5):293-7. PubMed ID: 12566930
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
[TBL] [Abstract][Full Text] [Related]
26. Is it All Said for NSAIDs in Alzheimer's Disease? Role of Mitochondrial Calcium Uptake.
Sanz-Blasco S; Calvo-Rodriguez M; Caballero E; Garcia-Durillo M; Nunez L; Villalobos C
Curr Alzheimer Res; 2018; 15(6):504-510. PubMed ID: 29283047
[TBL] [Abstract][Full Text] [Related]
27. Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation.
Thomas T; Nadackal TG; Thomas K
Neuroreport; 2001 Oct; 12(15):3263-7. PubMed ID: 11711868
[TBL] [Abstract][Full Text] [Related]
28. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.
Lim GP; Yang F; Chu T; Chen P; Beech W; Teter B; Tran T; Ubeda O; Ashe KH; Frautschy SA; Cole GM
J Neurosci; 2000 Aug; 20(15):5709-14. PubMed ID: 10908610
[TBL] [Abstract][Full Text] [Related]
29. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile.
Agdeppa ED; Kepe V; Petri A; Satyamurthy N; Liu J; Huang SC; Small GW; Cole GM; Barrio JR
Neuroscience; 2003; 117(3):723-30. PubMed ID: 12617976
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease.
Aisen PS
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S35-40. PubMed ID: 11992749
[TBL] [Abstract][Full Text] [Related]
31. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
Klegeris A; McGeer PL
Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
[TBL] [Abstract][Full Text] [Related]
32. Coxibs and Alzheimer's disease: should they stay or should they go?
Firuzi O; Praticò D
Ann Neurol; 2006 Feb; 59(2):219-28. PubMed ID: 16402383
[TBL] [Abstract][Full Text] [Related]
33. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
[TBL] [Abstract][Full Text] [Related]
34. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
35. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
[TBL] [Abstract][Full Text] [Related]
36. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models.
Cole GM; Morihara T; Lim GP; Yang F; Begum A; Frautschy SA
Ann N Y Acad Sci; 2004 Dec; 1035():68-84. PubMed ID: 15681801
[TBL] [Abstract][Full Text] [Related]
37. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
Aisen PS; Schafer KA; Grundman M; Pfeiffer E; Sano M; Davis KL; Farlow MR; Jin S; Thomas RG; Thal LJ;
JAMA; 2003 Jun; 289(21):2819-26. PubMed ID: 12783912
[TBL] [Abstract][Full Text] [Related]
38. Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-beta1-42.
Bate C; Veerhuis R; Eikelenboom P; Williams A
Neuroreport; 2003 Nov; 14(16):2099-103. PubMed ID: 14600505
[TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory drugs: a hope for Alzheimer's disease?
Hüll M; Lieb K; Fiebich BL
Expert Opin Investig Drugs; 2000 Apr; 9(4):671-83. PubMed ID: 11060701
[TBL] [Abstract][Full Text] [Related]
40. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
Dammann HG
Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
